Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery
Recruitment status was Not yet recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Both calcium channel antagonist and beta-blocker have cardioprotective effect. Endothelial shear stress is predictive factor of clinical outcomes in patients with obstructive stenosis.
The present study aims at comparing the re-distribution of shear stress and blood velocity during whole cardiac cycle after trans-coronary injection of Nicardipine and esmolol.
| Condition | Intervention | Phase |
|---|---|---|
|
Acute Coronary Syndrome Coronary Artery Disease |
Drug: Nicardipine , Esmolol |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Nanjing First Hospital, Nanjing Medical University |
- Endothelial shear stress assessed by computational fluid dynamics [ Time Frame: After four minutes ] [ Designated as safety issue: Yes ]At the peak effect of drug that the mean blood pressure (MBP) reduced by 10% or more, or the heart rate increased by 10-15 bpm.
- Minimal lumen area by intravascular ultrasound [ Time Frame: After four minutes ] [ Designated as safety issue: Yes ]At the peak effect of drug that the mean blood pressure (MBP) reduced by 10% or more, or the heart rate increased by 10-15 bpm.
| Estimated Enrollment: | 200 |
| Study Start Date: | October 2010 |
| Estimated Study Completion Date: | December 2010 |
| Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
-
Drug: Nicardipine , Esmolol
Blood flow-induced endothelial shear stress has strong effect on endothelial function and development or progression of plaque formation. It is extensively accepted that low and/or oscillating shear stress causes endothelial dysfunction and is one of crucial factors in localizing early atherosclerosis .In contrary, normal and high shear stress is atheroma protective and is involved in compensatory remodeling . Most studies reported that the endothelial shear stress distribution in often idealized geometrical models of human coronary arteries was the subject of numerous investigations , and in these studies it was shown that the geometry of coronary arteries is the main determinant of the observed shear stress distribution. Generally, downstream of a plaque, low shear stress can be expected, Several cardiovascular active drugs have been shown to be cardio-protective for patients with obstructive coronary disease. Of these drugs, calcium channel blocker is one of most prescribed in everyday clinical practice. Ninomiya et al. reported calcium channel blocker was associated with increased coronary diameter and blood fluid with dose-dependent pattern in patients with normal or mild stenotic coronary artery. However, no reports on the dynamic change of endothelial shear stress after calcium channel blocker in -vitron were published so far. As a result, the aim of this study was to evaluate the effect of intra-venous injection of Nicardipine, one calcium channel blocker with shorter half-time, on the re-distribution of endothelial shear stress in patients with acute coronary syndrome and mild stenotic (<50%) coronary artery disease.
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Diagnosis of unstable angina and non-Q wave myocardial infarction
- Age 18-75 yr.
- Diameter stenosis of coronary artery<70% diameter stenosis by visual estimation
- Blood pressure >110/70 mmHg
- Heart rate 60-~100 bpm, No cardiac arrhythmias
Exclusion Criteria:
- St-elevation myocardial infarction
- Lower blood pressure(<100/70mmHg)
- Heart rate <60 or >100 bpm, The presence of cardiac arrhythmias
- Allergy to study drugs
- Women in pregnancy
- Liver dysfunction
- Creatinine >2.5mg/dl
- Bleeding stroke within 6 months
- Left ventricular ejection fraction<30% before maximal medication
Contacts and Locations| Contact: Shaoliang Chen, Director | +86-25-52208048 | chmengx@126.com |
| China, Jiangsu | |
| Nanjing First Hospital,Nanjing Medical University | Not yet recruiting |
| Nanjing, Jiangsu, China, 210006 | |
| Contact: Shao-liang Chen, Director +86-25-52208048 chmengx@126.com | |
| Study Chair: | Shao-liang Chen, Director | Nanjing First Hospital,Nanjing Medical University |
More Information
No publications provided
| Responsible Party: | Shao-Liang Chen/Hospital director, Nanjing First Hospital |
| ClinicalTrials.gov Identifier: | NCT01171911 History of Changes |
| Other Study ID Numbers: | NJESS20103079 |
| Study First Received: | July 23, 2010 |
| Last Updated: | July 28, 2010 |
| Health Authority: | China: Ethics Committee |
Keywords provided by Nanjing Medical University:
|
Endothelial shear stress Calcium channel blocker |
Additional relevant MeSH terms:
|
Coronary Artery Disease Myocardial Ischemia Coronary Disease Acute Coronary Syndrome Heart Diseases Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases Angina Pectoris Chest Pain Pain Signs and Symptoms Calcium Channel Blockers Nicardipine |
Esmolol Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action Pharmacologic Actions Cardiovascular Agents Therapeutic Uses Vasodilator Agents Antihypertensive Agents Adrenergic beta-1 Receptor Antagonists Adrenergic beta-Antagonists Adrenergic Antagonists Adrenergic Agents Neurotransmitter Agents Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on May 19, 2013